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Nitrogen permease regulator-like 2 (NPRL2) is a
component of a conserved complex that inhibits
mTORC1 (mammalian Target Of Rapamycin Com-
plex 1) in response to amino acid insufficiency.
Here, we show that NPRL2 is required for mouse
viability and that its absence significantly compro-
mises fetal liver hematopoiesis in developing
embryos. Moreover, NPRL2 KO embryos have
significantly reduced methionine levels and exhibit
phenotypes reminiscent of cobalamin (vitamin B12)
deficiency. Consistent with this idea, NPRL2 KO liver
and mouse embryonic fibroblasts (MEFs) show
defective processing of the cobalamin-transport
protein transcobalamin 2, along with impaired lyso-
somal acidification and lysosomal gene expression.
NPRL2 KO MEFs exhibit a significant defect in the
cobalamin-dependent synthesis of methionine from
homocysteine, which can be rescued by supplemen-
tation with cyanocobalamin. Taken together, these
findings demonstrate a role for NPRL2 and mTORC1
in the regulation of lysosomal-dependent cobalamin
processing, methionine synthesis, and maintenance
of cellular re-methylation potential, which are impor-
tant during hematopoiesis.INTRODUCTION
The mTORC1 pathway regulates cellular growth by sensing
growth factors and nutrients, and relaying these signals to down-
stream effectors through its kinase activity (Dibble and Manning,
2013; Shimobayashi and Hall, 2014). Multicellular eukaryotes
rely on growth factor signaling as a means to communicate en-
ergy availability between tissues and cells, and significant prog-
ress has been made defining regulators of the pathways that
contribute to mTORC1 activity, including TSC1/2, AKT, and
PTEN (Inoki et al., 2005; Laplante and Sabatini, 2012). Activation
of mTORC1 results in the phosphorylation of targets such as S6Kinase and 4EBP1, which stimulate translation and growth. In
response to growth factor or nutrient insufficiency, mTORC1 is
inhibited by upstream negative regulators that act on small
GTPases that are important for mTORC1 function. The TSC1/2
complex is one such negative regulator whose loss leads to hy-
peractive mTORC1 signaling (Inoki et al., 2002; Manning et al.,
2002; Tee et al., 2002). Mutations in TSC1/2 are associated
with tuberous sclerosis and various forms of tumorigenesis, phe-
notypes that are consistent withmTORC1 dysregulation in tumor
formation (Guertin and Sabatini, 2007; Inoki et al., 2005).
Genetic studies in yeast revealed the existence of additional
upstream negative regulators of TORC1. An evolutionarily
conserved complex consisting of Npr2p, Npr3p, and Iml1p
(NPRL2, NPRL3, and DEPDC5 in mammals, respectively) was
identified to inhibit mTORC1 activity and induce autophagy in
response to specific nutrient limitations (Dokudovskaya et al.,
2011; Neklesa and Davis, 2009; Wu and Tu, 2011). Biochemical
studies of the Npr2 complex, termed SEACIT in yeast and
GATOR1 in mammals, have shown that it inhibits TORC1 activity
by functioning as a GTPase-activating protein (GAP) toward the
Rag family of small GTPases (Bar-Peled et al., 2013; Kira et al.,
2014; Panchaud et al., 2013). Consistent with these observa-
tions, mutants lacking Npr2, Npr3, or Iml1 fail to induce auto-
phagy and exhibit unchecked growth under specific nutrient
limitations (Sutter et al., 2013; Wu and Tu, 2011). The presence
of the Npr2 complex, but not TSC orthologs in single-cell eukary-
otes, suggests the NPRL2 complex might have a more ancestral
role in modulating mTORC1 activity in response to amino acid
availability. Loss of a genomic locus containing Nprl2 is
frequently associated with lung and other cancers (Bar-Peled
et al., 2013; Lerman andMinna, 2000; Li et al., 2004), suggesting
it might have tumor suppressive functions.
While a multitude of mTORC1 regulators contribute to diverse
physiological outcomes, as reviewed elsewhere (Laplante and
Sabatini, 2012), the in vivo function of NPRL2 in mammals has
not yet been addressed. To determine the physiological role of
NPRL2, we created a global Nprl2 knockout mouse. Here, we
show that NPRL2 KO animals have impaired fetal liver hemato-
poiesis and a methionine synthesis deficit. We further show
that loss of NPRL2 produces an apparent ‘‘folate-trap’’ and
implicate mTORC1 as a regulator of cobalamin (vitamin B12)-
dependent processes and cellular re-methylation potential.Cell Reports 12, 371–379, July 21, 2015 ª2015 The Authors 371
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Figure 1. Loss of NPRL2 Reduces Fetal
Liver Hematopoiesis
(A) Representative image of WT and NPRL2 KO
embryos at E12.5. Scale bar, 0.5 mm. Note the
microphthalmia and pale liver in NPRL2 KO em-
bryo. Scale bar, 2 mm.
(B) H&E staining of fetal liver sections of WT and
NPRL2 KO embryos at E12.5 show decreased
number of small, darkly stained cells in the NPRL2
KO indicative of reduced hematopoiesis. Scale
bar, 50 mM.
(C) Flow cytometric analysis of freshly isolated WT
and NPRL2 KO fetal livers at E12.5 labeled with
FITC-CD71, and APC-Ter119 antibodies show
decreased abundance of mature erythrocytes in
NPRL2 KO.
(D) Quantification of flow cytometry data (n = 6/
group). Values represent mean ± SD.
(E) mRNA levels of Nprl2 and erythroid-related
genes, including Gata1, Gata2, Fog1, Klf1, Cd71
Epo, and Hbb-y in WT, Nprl2+/, and NPRL2 KO
liver at E12.5 (n = 7, 10, and 6; respectively. N.D.,
not detectable). Data shown as mean ± SEM.
(F and G) Erythroid colony-forming units (CFU-E)
and erythroid burst-forming units (BFU-E) assays
were performed using isolated E12.5 livers and
show NPRL2 KO cells have reduced colony for-
mation (control n = 4; NPRL2 KO n = 3). *p < 0.05
versus control; **p < 0.01 versus control.These findings reveal a previously unrecognized mechanism
whereby a negative regulator of mTORC1 contributes to
hematopoiesis.
RESULTS
Defective Hematopoiesis in NPRL2 KO Embryos
To determine the function of NPRL2 in vivo, we created a global
knockout of Nprl2 in mice (Figure S1). Breeding heterozygous
animals did not produce NPRL2 KO pups, but E12.5 embryos
were obtained for analysis. Gross phenotypic observation
showed NPRL2 KO embryos were smaller than wild-type (WT)
in size, and displayed microphthalmia, occasional unilateral
anopthalmia, and notably pale liver (Figure 1A). Histological
examination of the fetal livers showed reduced hematopoietic
precursor cells in the NPRL2 KO compared to WT littermates
(Figure 1B). Flow cytometry of isolated fetal livers targeting
cell-surface markers CD71 and Ter119 showed impaired
erythroid differentiation in the NPRL2 KO, with increased per-
centages of early progenitors and reduced percentages of
late progenitors (Figures 1C and 1D). Quantitative RT-PCR of
erythroid-related genes, including Gata1, Fog1, Klf1, and
Cd71, showed they were significantly decreased in the NPRL2
KO compared to Nprl2+/ and WT (Figure 1E). Consistent with372 Cell Reports 12, 371–379, July 21, 2015 ª2015 The Authorsa defect in fetal liver hematopoiesis, fetal
hemoglobin Hbb-y mRNA was signifi-
cantly reduced in the NPRL2 KO liver,
whereas the expression of Epo was
significantly increased, possibly due to
feedback regulation resulting from ineffi-cient erythropoiesis. To determine whether hematopoiesis was
defective in the early differentiation cascade, fetal livers were
isolated and used to determine the capacity of hematopoietic
stem cells to differentiate into erythroid-colony forming units
(CFU-e) and more immature erythroid-blast forming units
(BFU-e) (Figures 1F and 1G). Both types of colonies formed in
WT and NPRL2 KO cultures; however, the number of colonies
was significantly reduced in NPRL2 KO. These data suggest
NPRL2 KO embryos have an early defect in hematopoiesis, re-
sulting in reduced numbers of erythroid progenitor cells. Analysis
of Nprl2+/ and WT blood from 20-week-old mice did not show
any hematological differences by complete blood count with dif-
ferential analysis (Figure S1), suggesting that one functional
Nprl2 allele is sufficient for normal production of blood cells.
Altered Metabolism in NPRL2 KO Embryos
Previousmetabolic characterization of yeast npr2Dmutants sug-
gested that disruption of mammalian Nprl2may alter amino acid
metabolism in the developing embryo (Laxman et al., 2014). We
obtainedWT,Nprl2+/, andNPRL2KOembryos at E12.5 andper-
formed targeted liquid chromatography-tandemmass spectrom-
etry (LC-MS/MS) analysis of whole-embryo metabolite extracts.
Intriguingly, metabolomic analysis showedmarkedly lower abun-
dance of methionine and elevated 5-methyltetrahydrofolate
Table 1. Relative Metabolite Amount from E12.5 WT and NPRL2
KO Embryos Determined by Targeted LC-MS/MS
Metabolite Q1/Q3 m/z Wild-Type NPRL2 KO
Methionine:folate Cycle
Methionine 150.1/104.1 1.00 ± 0.02 0.71 ± 0.03a
150.1/133.0 1.00 ± 0.02 0.72 ± 0.03a
5-Me-THF 460.1/313.3 1.00 ± 0.06 1.58 ± 0.19b
460.1/180.1 1.00 ± 0.07 1.50 ± 0.20c
SAM 399.1/250.2 1.00 ± 0.04 1.02 ± 0.10
399.1/136.0 1.00 ± 0.03 0.92 ± 0.07
SAH 385.1/136.2 1.00 ± 0.08 1.18 ± 0.09
385.1/134.0 1.00 ± 0.09 1.19 ± 0.10
N,N-Dimethylglycine 104.0/58.1 1.00 ± 0.02 0.78 ± 0.06b
104.0/42.0 1.00 ± 0.03 0.86 ± 0.03c
Betaine 118.1/72.2 1.00 ± 0.17 1.12 ± 0.15
Amino Acids
Isoleucine 130.0/82.1 1.00 ± 0.10 0.47 ± 0.07b
130.0/45.2 1.00 ± 0.13 0.43 ± 0.06b
Leucine 130.0/84.0 1.00 ± 0.08 0.51 ± 0.06a
Glutamine 144.9/127.2 1.00 ± 0.04 0.34 ± 0.05a
144.9/109.0 1.00 ± 0.05 0.36 ± 0.04a
Glutamate 148.1/84.1 1.00 ± 0.04 0.92 ± 0.04
148.1/130.1 1.00 ± 0.04 0.88 ± 0.03c
Valine 118.1/72.1 1.00 ± 0.02 0.67 ± 0.03a
118.1/55.0 1.00 ± 0.02 0.66 ± 0.03a
Cysteine 122.0/58.9 1.00 ± 0.12 1.18 ± 0.06
122.0/76.1 1.00 ± 0.09 1.05 ± 0.10
Proline 116.0/70.1 1.00 ± 0.06 0.89 ± 0.05
116.0/69.0 1.00 ± 0.07 0.89 ± 0.04
Tyrosine 182.1/136.1 1.00 ± 0.04 0.74 ± 0.03a
182.1/91.0 1.00 ± 0.04 0.72 ± 0.03a
Tryptophan 205.1/188.2 1.00 ± 0.05 0.86 ± 0.04c
205.1/146.2 1.00 ± 0.05 0.84 ± 0.03c
Arginine 175.1/70.1 1.00 ± 0.04 0.68 ± 0.04a
175.1/116.0 1.00 ± 0.04 0.67 ± 0.05a
Histidine 156.1/110.0 1.00 ± 0.02 0.81 ± 0.06c
156.1/83.2 1.00 ± 0.04 0.69 ± 0.04a
Phenylalanine 166.1/120.1 1.00 ± 0.03 0.80 ± 0.05b
166.1/103.2 1.00 ± 0.04 0.75 ± 0.04b
ap < 0.001 versus WT (n = 4–7).
bp < 0.01 versus WT.
cp < 0.05 versus WT.(5-Me-THF) in NPRL2 KO embryos, compared to WT (Table 1).
These metabolic differences suggest the presence of a ‘‘folate
trap’’ (Herbert and Zalusky, 1962; Scott and Weir, 1981), a
hallmark of defective methionine synthase (MTR) and cobal-
amin-deficient anemia (Koury and Ponka, 2004). We also
analyzed metabolites of betaine-homocysteine methyltransfer-
ase (BHMT), an alternative pathway of methionine synthesis that
uses betaine as a methyl donor. We observed a decrease in
N,N-dimethylglycine and reduced BHMT mRNA levels in theNPRL2 KO (Table 1; Figure S2A), suggesting no significant
compensation by this pathway. The abundance of several other
amino acids was reduced in the NPRL2 KO, including leucine,
isoleucine, and glutamine, while most others remained largely
unchanged (Table 1). Importantly, not all metabolites were
repressed in the NPRL2 KO as assessed by our targeted detec-
tion methods (Table 1; Table S1). Nucleic acid moieties were
significantly increased in the NPRL2 KO, whereas several glyco-
lytic andTCA intermediateswere reduced, consistentwithaltered
folate and one-carbon metabolism (Table 1; Table S1).
The significant changes in methionine levels prompted us to
examine the expression of genes pertaining to methionine,
folate, and cobalaminmetabolism, as well as the transsulfuration
pathway in embryonic liver (Figure S2A). Folate-related genes
(Dhfr,Mthfr) were unchanged in NPRL2 KO versus WT; however
Mtr and the lysosomal transporter for cobalamin (Lmbrd1) were
moderately induced in the NPRL2 KO. Expression of Cth, part of
the transsulfuration pathway, was induced in the NPRL2 KO.
These data indicate that expression of genes involved in sulfur
amino acid metabolism is influenced by the loss of NPRL2
despite no apparent increase in pS6K and pmTOR in liver at
E12.5 (Figure S2B).
mTORC1 and Lysosomal Dysfunction in NPRL2 KO Cells
To test whether complete loss of NPRL2 altered mTORC1-
dependent pathways, mouse embryonic fibroblasts (MEFs) cells
were generated from E12.5 embryos. Consistent with previous
NPRL2 knockdown studies (Bar-Peled et al., 2013), NPRL2 KO
MEF cells were unable to repress mTORC1 activity during star-
vation in Earle’s buffered saline solution (EBSS) and retained
phosphorylation of S6K and 4EBP1, compared toWT (Figure 2A).
To determine whether the phosphorylation of S6K in the NPRL2
KO cells was due to dysregulated mTORC1 activity, NPRL2 KO
cells were treated with either rapamycin or torin 1 during EBSS
incubation. Both pharmacological mTORC1 inhibitors reduced
S6K phosphorylation in NPRL2 KO cells, suggesting that
NPRL2 regulates mTORC1 activity (Figure 2B). Moreover, the
amount of p62, a ubiquitin-binding protein that is degraded by
autophagy, was increased in the NPRL2 KO MEF cells and not
degraded during EBSS stimulation suggesting defective auto-
phagy or lysosomal function (Figure 2B). These data collectively
indicate that NPRL2 KO MEFs exhibit hallmarks of active
mTORC1 signaling despite starvation, consistent with its role
as a negative regulator of TORC1.
Since mTORC1 inhibition is necessary for the acidification of
lysosomes during autophagy (Zhou et al., 2013), we tested
whether NPRL2 KO MEF cells had altered rates of lysosomal
acidification. We utilized hybrid ultra pH-sensitive nanoprobes
to quantitate lysosomal acidification over a time course with
EBSS starvation (Ma et al., 2014; Zhou et al., 2011). WT MEF
cells showed a significant and rapid increase in early-endosome
and late-endosome/lysosome acidification over the starvation
period (Figures 2C, 2D, and S4A–S4D). In contrast, NPRL2 KO
MEF cells did not show compartmental pH difference between
nutrient-rich or starved conditions, consistent with impaired
lysosomal function (Mindell, 2012). Moreover, WT MEF cells
overexpressing the GTP-locked RagA Q66L mutant had similar
defects in acidification (Figure S3E), which supports the reportedCell Reports 12, 371–379, July 21, 2015 ª2015 The Authors 373
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Figure 2. Dysregulation of Lysosomal-
Related Function in NPRL2 KO MEF Cells
(A)WT andNPRL2 KOMEF cells cultured in Earle’s
buffered saline solution (EBSS) for 1, 3, and 6 hr.
Western blot analysis was used to determine the
abundance of NPRL2, pS6K (T389), total S6K,
p4EBP1 (T37/46), 4EBP1, and b-actin.
(B) WT and NPRL2 KO MEF cells were cultured in
either complete media (Full) or EBSS for 1 hr in the
presence of 10 nM rapamycin or 250 nM torin 1.
Western blot analysis was performed to determine
the abundance of NPRL2, p62, pS6K (T389), total
S6K, and b-actin.
(C and D) Confocal microscopy of WT and NPRL2
KO MEF cells treated with 100 mg/ml hybrid ultra
pH-sensitive nanoprobes was used to determine
the intracellular vesicle pH of cells cultured in full
media or EBSS over a 120-min period. Relative
fluorescence of nanoprobes at pH 6.2/6.9 indi-
cating early endosome acidification and pH 5.3/
6.9 indicating late endosome and lysosomal
acidification was determined. (Similar data were
obtained from replicate experiments with two to
five cells per group. a, p < 0.02; b, p < 0.001 WT
EBSS versusWT full; *WT EBSS versus KO EBSS.)
(E) Quantitative RT-PCR analysis of TFEB target
genes, including Atp6v1h, Arsa, Clcn7, Neu1, and
Gla in WT and NPRL2 KO MEF cells incubated for
6 hr in EBSS in the presence or absence of torin 1.
Data represent mean ± SEM; **p < 0.01; n.s., not
significant.
(F)WT andNPRL2KOMEF cells expressing TFEB-
GFP were analyzed by fluorescent microscopy to
determine TFEB localization in complete media,
and after 2 hr incubation in EBSS in the presence
and absence of torin 1.function of the NPRL2-containing complex as a GAP for the
Rag GTPases (Bar-Peled et al., 2013; Panchaud et al., 2013).
In addition, pretreatment of Nprl2 KO cells with torin 1 increased
acidification similar to WT cells in EBSS (Figure S3F). These data
suggest particular lysosomal activities requiring low pH may be
impaired during starvations in the NPRL2 KO cells.
We next investigated whether the regulation of genes involved
in lysosomal biogenesis was altered by loss of NPRL2. Quantita-
tive RT-PCR of lysosomal gene targets of the transcription factor
TFEB (Sardiello et al., 2009), including Atp6v1h, Arsa, Clcn7,
Neu1, and Gla showed that their induction by EBSS was depen-
dent on NPRL2 expression and mTORC1 inhibition (Figure 2E).
We then transfected WT and NPRL2 KO MEF cells with TFEB-
GFP to determine whether the nuclear localization of TFEB in
response to starvation might be compromised in the absence
of NPRL2. In nutrient-rich media, TFEB retained its cytoplasmic
localization in both cell types, but localized to the nucleus during
EBSS incubation in WT MEF cells, not NPRL2 KO (Figure 2F).
Since the localization of TFEB to the nucleus is dependent
on mTORC1 repression (Sardiello et al., 2009), we treated WT
and NPRL2 KO cells with torin 1 during the switch to EBSS.
Treatment of NPRL2 KO cells with torin 1 caused TFEB to
localize to the nucleus, consistent with induction of TFEB target
genes, suggesting lysosomal gene expression is dependent on
mTORC1 inhibition by NPRL2.374 Cell Reports 12, 371–379, July 21, 2015 ª2015 The AuthorsDefective Cobalamin-Dependent Metabolism in NPRL2
KO Cells
We realized that defects in lysosomal functionmight help explain
the reduced methionine amounts in NPRL2 KO embryos. The
methionine synthase enzyme is dependent on cobalamin
(vitamin B12), which is carried in plasma bound to the cobal-
amin-transport protein, called TCN2, and transported into cells
by the endocytic-lysosomal pathway (Banerjee and Matthews,
1990; Rosenblatt et al., 1985; Youngdahl-Turner et al., 1978).
Western blot analysis showed increased abundance of TCN2
in both NPRL2 KO embryonic liver and MEF cells, compared
with WT (Figure 3A). These data suggested a cell-autonomous
regulation of cobalamin metabolism could impact methionine
synthesis. Notably, NPRL2 KOMEF cells expressed significantly
lower levels of Tcn2 mRNA, compared to WT, suggesting a
negative feedback due to high TCN2 protein uptake (Figure 3B).
We assayed TCN2 uptake in WT and NPRL2 KOMEF cells using
cobalamin-loaded, 35S-labeled TCN2. Both WT and NPRL2
KO cells took up the protein, and EBSS stimulated the effect
(Figure 3C). Pulse-chase experiments with 35S-labeled TCN2
showed that continued incubation of cells in unlabeled media
reduced intracellular 35S-TCN2 in WT MEF cells to a greater
extent than NPRL2 KO cells. Since NPRL2 KO cells display
impaired lysosomal function, these data could explain the
increased TCN2 content in NPRL2 KO (Figure 3A). Treating WT
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Figure 3. Defective TCN2 Processing,
Cobalamin Deficiency, and Impaired Methi-
onine Synthesis in NPRL2 KO MEF Cells
(A) Western blot analysis of TCN2 and b-actin
show increased TCN2 protein content in NPRL2
KO fetal liver andMEFs cells, relative to WT. (R.D.,
relative densitometry)
(B) qRT-PCR analysis of TCN2 mRNA show
decreased expression in the NPRL2 KO MEF
cells, relative to WT MEF cells (n = 3/group). Data
represent mean ± SEM.
(C) 35S-TCN2 assays were performed in WT and
NPRL2 KO MEF cells incubated with labeled-
TCN2 for 2 hr in (A) complete media, (B) EBSS
starvation media, (C) EBSS followed by a 4-hr
switch to non-labeledmedia, or (D) EBSS followed
by a 4-hr switch to complete media with 100 nM
bafilomycin A. Phosphorimager measurements of
35S-TCN2 in cell lysates were normalized to total
protein. Data represent three independent exper-
iments. Data represent the mean ± SEM of three
independent experiments. *p < 0.05; **p < 0.01.
(D) WT and NPRL2 KOMEF cells were cultured for
4 days in methionine-deficient media, supple-
mented with increasing concentrations of methi-
onine. Cell viability was determined by cell-titer
glo analysis. Data represent the mean ± SEM.
n = 3/group, *p < 0.01; **p < 0.001.
(E) WT and NPRL2 KO MEF cells (20,000/well)
were cultured for 4 days in methionine-deficient
media with 1% HI FBS (control) in the presence
or absence of 200 mM L-methionine or 200 mM
L-homocysteine and 250 nM cyanocobalamin. In
contrast to WT cells, NPRL2 KO cells die when
media is supplemented with L-homocysteine
alone but are able to proliferate with L-homocys-
teine and cyanocobalamin supplementation for
proliferation. Cell number was determined with
trypan-blue exclusion and automated cell count-
ing. Data represent two independent experiments
performed in duplicate.
(F) WT and NPRL2 KO MEF cells were cultured in
methionine-deficient media with 200 mM homo-
cysteine-3,3,4,4-D4 for 24 hr. Metabolite extracts were analyzed by LC-MS/MS to determine the synthesis of heavy-labeled [D4]-methionine and [D4]-SAM. Data
were normalized against NPRL2 KO. Data represent the mean ± SEM of two independent experiments performed in duplicate; *p < 0.05.
(G) Model depicting NPRL2-regulated functions during the starvation response.cells with the lysosomal V-ATPase inhibitor, bafilomycin A1, dur-
ing the incubation period caused retention of TCN2 protein, indi-
cating TCN2 is indeed processed by lysosomes.
To assess whether the defects in methionine synthesis in
NPRL2 KO embryos could be recapitulated in a cell-culture
model, WT and NPRL2 KO MEF cells were cultured in various
nutrient conditions. Although similar proliferation rates of WT
andNPRL2KOMEF cells were observed in completemedia (Fig-
ure S4A), NPRL2 KO cell viability was more sensitive to methio-
nine depletion, compared to WT cells (Figure 3D). We tested
whether NPRL2 KO cells might exhibit altered sensitivity to
anti-folate treatments, using a dose responsewithmethotrexate,
but found no difference (Figure S4B). We thenmeasured prolifer-
ation of low-passage fibroblasts in methionine-deficient media,
in the presence and absence of methionine or homocysteine
supplementation. The synthesis of methionine from homocyste-ine requires the cobalamin-dependent enzyme methionine syn-
thase. WT MEF cells were able to proliferate in media containing
1% HI-FBS and either methionine or homocysteine. In striking
contrast, NPRL2 KO MEF cells only grew in media containing
methionine (Figure 3E). These data are consistent with defective
cobalamin metabolism in the NPRL2 KO cells and suggest
NPRL2 is necessary for maintaining the cellular demand of
methionine synthesis from homocysteine. We next asked
whether the NPRL2 KO phenotype could be rescued by exoge-
nous cobalamin treatment. Remarkably, supplementation of
cyanocobalamin permitted growth of NPRL2 KOMEF cells in ho-
mocysteine, at rates comparable to WT cells (Figure 3E).
To directly test whether NPRL2 KO MEF cells harbored a
defect in the cobalamin-dependent synthesis of methionine
from homocysteine, we quantitated the conversion of homocys-
teine to methionine using LC-MS/MS. WT and NPRL2 KO MEFCell Reports 12, 371–379, July 21, 2015 ª2015 The Authors 375
cells were incubated in methionine-deficient media and supple-
mented with labeled homocysteine-3,3,4,4-d4 for a 24-hr period.
WT MEF cells synthesized approximately 4-fold more methio-
nine and 5-fold more SAM from labeled-homocysteine,
compared to NPRL2 KO cells (Figure 3F). Treatment of WT cells
with torin 1 for 4 hr slightly increased methionine synthesis from
labeled homocysteine, in contrast to NPRL2 KO cells (Fig-
ure S4C). Collectively, these data strongly suggest that loss of
NPRL2 produces cobalamin deficiency and thus methionine
deficiency, perhaps due to defective lysosomal-dependent
TCN2 processing (Figure 3G).
DISCUSSION
In this report, we show an important role for NPRL2 in the regu-
lation of amino acidmetabolism and fetal hematopoiesis. Loss of
NPRL2 leads to low methionine and high 5-Me-THF amounts in
embryos, suggesting a ‘‘folate trap’’ that can occur by cobalamin
deficiency (Herbert and Zalusky, 1962). We further observe that
lysosomal processing of cobalamin is downstream of NPRL2
and establish mTORC1 as a regulator of cobalamin-processing
and the cobalamin-dependent enzyme, methionine synthase.
Comprehensive studies of human inborn errors of cobalamin
metabolism have uncovered multiple proteins in this pathway
that regulate the availability of cobalamin in cells, but thus far
have not examined mTORC1 as a regulatory pathway (Watkins
and Rosenblatt, 2013). Our observations suggest that mTORC1
repression is essential for lysosomal processing of TCN2 for the
bioavailability of cobalamin for methionine synthase (Banerjee
and Matthews, 1990). This enzyme resides at the intersection
of the methionine and folate cycle and influences flux through
these pathways. Defects in either pathway can present with
similar hematological pathologies, but distinct metabolic profiles
(Carmel et al., 2003). Collectively, our findings reveal that NPRL2,
a negative regulator of mTORC1, controls cobalamin availability,
methionine homeostasis, and re-methylation potential, which
are important metabolic pathways for hematopoiesis (Klee,
2000; Koury and Ponka, 2004).
Previous studies have shown that growth-factor-dependent
regulators of mTORC1, including PTEN and TSC1, contribute
to hematopoiesis (Chen et al., 2008; Gan et al., 2008; Knight
et al., 2014; Yilmaz et al., 2006). A surprising result from our
studies is that NPRL2 KO animals do not phenocopy RagA
GTPase-deficient mice, which do not present with malforma-
tions of the eye, nor pallor (Efeyan et al., 2013). In contrast, the
constitutively GTP-bound RagA mutant mice are born alive but
succumb shortly after birth. These phenotypic differences may
be explained by genetic background differences, compensatory
effects of the other Rag proteins, or the possibility that NPRL2
has additional functions in vivo. Our observations, however,
are consistent with the idea that dynamic regulation of mTORC1
is required for red blood cell development, which has been
observed in other genetically engineered mouse models of dys-
regulated mTORC1 (Chen et al., 2008; Gan et al., 2008; Knight
et al., 2014; Yilmaz et al., 2006). The combined early lethality
and hematopoietic phenotype of NPRL2 KO embryos is consis-
tent with additional lysosomal pathway defects, including the
failure to activate lysosomal gene transcription in response to376 Cell Reports 12, 371–379, July 21, 2015 ª2015 The Authorsstarvation. Striking microphtalmia in the NPRL2 KO embryos is
consistent with a dysfunction of micropthalmia-associated tran-
scription factor, another known lysosomal-regulated transcrip-
tion factor (Roczniak-Ferguson et al., 2012; Steingrı´msson
et al., 1994). The consequence of dysregulated lysosomal gene
transcription likely contributes to extra-hematologic deficiencies
and will be of interest in future studies.
Our finding that NPRL2 KO embryos have reduced hemato-
poietic progenitor cells is consistent with a special requirement
for methionine metabolism in the maintenance and proliferation
of embryonic stem cells (Shiraki et al., 2014). As starvation-
induced lysosomal acidification is impaired in NPRL2 KO cells,
these data are consistent with the observation that mTORC1
inactivation is required for lysosomal acidification (Zhou et al.,
2013), which if compromised could result in defective TCN2 pro-
cessing (Rosenblatt et al., 1985; Youngdahl-Turner et al., 1978).
Interestingly, complete loss of RagA/B also results in defective
lysosomal acidification (Kim et al., 2014), similar to NPRL2 KO
cells that harbor RagA/B in the GTP-locked state. These obser-
vations suggest that cycling of the Rag GTPases between GTP-
and GDP-bound states may be required for proper lysosomal
acidification.
NPRL2 functions in a complex with two other proteins, NPRL3
and DEPDC5, which are each indispensable for proper nutrient
regulation of mTORC1 (Bar-Peled et al., 2013; Kira et al., 2014;
Neklesa and Davis, 2009; Wu and Tu, 2011). Although loss of
NPRL3 has been studied in mice by deleting the Nprl3 promoter
region (Kowalczyk et al., 2012), the mice do not delete NPRL3
expression in erythroid cells making comparisons to our global
NPRL2 KO model challenging. Intriguingly, the NPRL3 gene
locus is proximal to a-globin cluster in mice, indicating cis
elements in this region may contribute to NPRL3 and a-globin
expression. While no reports have directly investigated the func-
tion of DEPDC5, recent studies have shown DEPDC5 mutations
are associated with epilepsy in humans (Dibbens et al., 2013).
These observations are intriguing since cobalamin deficiencies
may contribute to seizure activity (Akaike et al., 1993; Kumar,
2004) and indicate that the NPRL2 complex may contribute to
neurological pathologies that are sensitive to cobalamin (Stabler,
2013).
Methionine dependence of cancer cells is a hallmark of many
tumors (Agrawal et al., 2012; Glaudemans et al., 2013). Our
observation that loss of Nprl2 causes stricter methionine depen-
dence and re-methylation deficits suggests that cells lacking
NPRL2 may consequently exhibit increased methionine uptake
and dependency. Consistent with this idea, yeast npr2D
mutants have significantly higher levels of SAM, which may pro-
mote their unchecked growth under particular nutrient starva-
tions (Laxman et al., 2013; Sutter et al., 2013). Although budding
yeast do not utilize cobalamin for the synthesis of methio-
nine, the similar phenotype linked to methionine metabolism
compared to mammalian cells suggests an ancient, conserved
function for this complex and TORC1 centered on methionine
and SAM homeostasis. Future work will determine whether
loss of Nprl2, or other negative regulators of mTORC1, in-
creases the demand for methionine in tumors and whether
methionine limitation might represent a therapeutic strategy to
compromise their growth.
In summary, we describe an unanticipated role for NPRL2 in
the regulation of lysosomal processing of cobalamin in mam-
mals, which is critical during hematopoiesis. These results pro-
vide mechanistic support for an intimate link between the
mTORC1 signaling pathway and its proper regulation required
during hematopoiesis (Knight et al., 2014; Yilmaz et al., 2006).
Our study suggests a key metabolic requirement during blood
cell formation could be the proper coordination of re-methyl-
ation potential with the demands of DNA nucleotide synthesis.
We conclude that NPRL2 coordinates a cellular response
to amino acid starvation by orchestrating the uptake and
bioavailability of cobalamin, which, in turn, is required for the
synthesis of the sentinel metabolites methionine and SAM
that play critical roles in the regulation of cell growth and
homeostasis.
EXPERIMENTAL PROCEDURES
Generation of NPRL2 KO Mice
The Nprl2 targeting vector was created using the pGKNeoF2L2DTA (Addgene,
#13445). A 5-kb long arm harboring the Nprl2 promoter, a 2.9-kb fragment
harboring exons 1–9, and a 1.6-kb short arm harboring exons 10 and 11 of
the Nprl2 gene were generated by high-fidelity polymerase amplification
(PfuUltra, Stratagene). The Nprl2 targeting vector was linearized with AloI
(Thermo Scientific) and injected into ES cells. ES clones were isolated,
screened for homologous recombination by PCR, and verified by Southern
blot analysis. Validated homologous recombined clones were injected into
3.5-day C57BL/6 blastocysts, and the resulting chimeras were crossed with
C57BL/6 females to obtain germline transmission of the targeted Nprl2 allele
(Nprl2neo-loxP/+). The Nprl2 gene was deleted by crossing Nprl2loxP/+ mice
with female Zp3-cre (C57BL/6) to generate the Nprl2+/ mice. Removal of
the Zp3-cre allele and deletion of the Nprl2 gene were confirmed by PCR gen-
otyping with primers listed in Table S3. Nprl2+/ mice were backcrossed to
C57BL/6 mice at least four generations, and subsequent heterozygous
crosses, resulting in littermates of Nprl2+/+, Nprl2+/, and Nprl2/ (NPRL2
KO), were used in the studies. See also Figure S1.
Flow Cytometry Analysis of Erythropoiesis
Nprl2+/ mice were crossed, and embryonic livers were collected at E12.5 by
decapitation of the dam and excision of the fetal liver into sterile PBS with 2%
FBS and analyzed as previously described (Zhang et al., 2003). Briefly, cells
were isolated by trituration, passed through a 70-mM nylon mesh cell strainer
(Falcon), immunolabeled at 4C with FITC-CD71 (1:200 dilution; BD, #553266)
and APC-Ter119 (1:200 dilution; BD, #557909) antibodies for 15 min, pelleted,
and re-suspended in PBS with 2% FBS and 3 mg/ml propidium iodide. Flow
cytometry was carried out on a BD FACSCalibur and analyzed using FlowJo
V8.8.4.
Colony Assays
For CFU-E and mature BFU-E assays, E12.5 fetal liver cells were isolated and
plated in Methocult media with erythropoietin (M3334, STEMCELL Technolo-
gies) following the manufactures protocol. Cells were cultured at 37C and 5%
CO2 in a humidified incubator, and colonies were scored on day 2 (CFU-E) and
day 4 (BFU-E).
Analysis of Methionine Synthesis
WT and NPRL2 KO MEF cells were incubated in methionine-deficient
media, consisting of DMEM (GIBCO, #21013-024), 1 3 GlutaMAX (GIBCO,
35050-061), 200 mM L-cysteine (Sigma), 5% FBS (GIBCO, #10082-147), and
200 mM DL-Homocysteine-3,3,4,4-d4 (CDN Isotopes, D-6452), for 24 hr.
Metabolites were extracted from cells in ice-cold extraction buffer with 0.3%
formic acid and processed for LC-MS/MS. Synthesis of metabolites from
labeled-homocysteine was calculated relative to total ion counts for each
sample.TCN2 Uptake Assay
TCN2 was cloned from duodenum of C57/B6 and inserted in the pCI vector
(Promega). 35S-incoporation was performed by using the TNT Quick Coupled
Transcription/Translation kit (Promega), according to the manufacturer’s pro-
tocol. The 35S-TCN2 labeling reaction was loaded with 1 mg/ml cyanocobal-
amin for 15 min and dialyses in PBS overnight at 4C in a 10,000 MWCO
Slide-A-Lyzer cassette (Thermo Scientific). Cells were treated with 35S-TCN2
as described in the figure legends, washed twice with PBS, and harvested in 2
3 Laemmli sample buffer. Protein lysates were separated by SDS-PAGE and
exposed to a phosphorimager screen for 48 hr and imaged with a Typhoon
scanner (Amersham Biosciences).
Statistical Analysis
Statistical analysis was performed by two-tailed Student’s t test using Micro-
soft Excel 2010. A p value <0.05 was considered significant.
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